Yahoo Web Search

  1. Kahn Brothers Trims New York Times, Hologic Positions

    GuruFocus.com via Yahoo FinanceMay 08 21:15 PM

    Founded in 1978, Kahn Brothers (Trades, Portfolio) & Co. Inc. currently manages more than $800 million in assets. Warning! GuruFocus has detected 3 Warning Sign with BOM:532772. The trade had an impact of -2.24% on the portfolio.

  2. Edited Transcript of MRK earnings conference call or presentation 30-Apr-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 03 5:08 AM

    Q1 2019 Merck & Co Inc Earnings Call WHITEHOUSE STATION May 3, 2019 (Thomson StreetEvents) -- Edited Transcript of Merck & Co Inc earnings conference ...

  3. Stocks recently featured in the blog include: Merck MRK, Pfizer PFE, AbbVie ABBV, Sanofi SNY and Glaxo GSK. This week was a relatively busy one for the pharma sector, marked by earnings ...

  4. Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More

    Zacks via Yahoo FinanceMay 08 14:38 PM

    Per the Earnings Trends report, the companies from this sector, which reported till May 1 and constitute more than 80% of the sector’s market capitalization, recorded 8.9% earnings growth and ...

  5. The index gained 0.3% on Friday after first-quarter U.S. GDP expanded at a rate higher than the consensus estimate for the period. The Dow finished the day just 1.5% below its all-time high.

  6. While policy makers are widely expected to leave the central bank's key short-term interest rate unchanged, market participants are likely to try to glean insights into the Fed's thinking on ...

  7. ImmunoGen (IMGN) Misses on Earnings & Revenues in Q1

    Zacks via Yahoo FinanceMay 06 13:44 PM

    ImmunoGen, Inc. IMGN reported adjusted loss of 30 cents per share for the first quarter of 2019, wider than the Zacks Consensus Estimate of a loss of 28 cents. ImmunoGen’s shares have ...

  8. The S&P 500 eked out another record high close on Tuesday and capped its best four-month stretch in nearly nine years after a recent rally that helped to restore investors' belief in the decade-long ...

  9. Aduro has a collaboration and license agreement with Novartis NVS for developing its lead STING Activator candidate, ADU-S100. In February this year, Aduro dosed the first patient in a phase ...

  10. You can see all of today's research reports here >>> Berkshire Hathaway's shares have underperformed the Zacks Insurance - Property and Casualty industry year to date (+4.4% vs. +6.4%). Berkshire ...

  1. Ads
    related to MERCK & CO., INC